Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
08/28/2008 | US20080207510 Modified vitamin k-dependent polypeptides |
08/28/2008 | US20080207487 Manufacturing process for the production of polypeptides expressed in insect cell-lines |
08/28/2008 | US20080206375 Composition of Radix Codonopsis and Radix Astragali, a Method for Preparation Thereof and its Application |
08/28/2008 | US20080206374 Purification, washing with deionized water, heating and extracting, condensing, depositing with ethanol; immunomodulators, antiischemic agents |
08/28/2008 | US20080206362 Bathtub with carbon dioxide gas nanobubble-producing section therein |
08/28/2008 | US20080206312 Therapeutic Morpholino-Substituted Compounds |
08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
08/28/2008 | US20080206247 Glycoprotein VI fusion proteins |
08/28/2008 | US20080206208 Adipose tissue culture use in treatment and prevention of cardiomyopathies; tissue engineering; regenerative medicine |
08/28/2008 | CA2676786A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
08/27/2008 | EP1961811A1 Novel cytokine ZCYTOR17 ligand |
08/27/2008 | EP1961760A2 Peptides and compounds that bind to a thrombopoietin receptor |
08/27/2008 | EP1961759A1 Integrin targeted cyclopeptide ligands, their preparation and use |
08/27/2008 | EP1961425A2 Methods and compositions for the prevention and treatment of anemia |
08/27/2008 | EP1960372A1 Kinase inhibitors and their uses |
08/27/2008 | EP1807095A4 Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (hit) syndrome |
08/27/2008 | EP1697318B1 Prolinylarylacetamides |
08/27/2008 | EP1337560B1 Truncated cd200 |
08/27/2008 | EP1234025B1 Human enzymes of the metalloprotease family |
08/27/2008 | CN101253264A 抗血小板膜糖蛋白Ⅵ单克隆抗体 Anti-platelet membrane glycoprotein monoclonal antibody Ⅵ |
08/27/2008 | CN101253172A N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
08/27/2008 | CN101252943A Use of lactobacillus for increasing the absorption of a metal chosen from Fe, Zn, Ca and ions thereof |
08/27/2008 | CN101252939A Steroidal glycoside compounds as core 2N-glcnac-t inhibitors |
08/27/2008 | CN101252938A Combined preparation of a thiazide diuretic and a loop diuretic |
08/27/2008 | CN101249257A Traditional Chinese medicine preparation for curing edematous |
08/27/2008 | CN101249221A Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus |
08/27/2008 | CN101249209A Nosebleed stopping powder and method of preparing the same |
08/27/2008 | CN101249193A Chinese medicinal composition for curing gynecology hemorrhagic disease |
08/27/2008 | CN101249176A Chinese medicine prescription for steaming and soaking foots |
08/27/2008 | CN101249154A Nourishing blood soothe the nerves oral liquid |
08/27/2008 | CN101249149A Pharmaceutical combination for intestinal tract hemostasia and method of preparing the same |
08/27/2008 | CN101249118A Chinese medicine extract and medicine use thereof |
08/27/2008 | CN101249063A Calciparine/sodium salt nano oral preparation and preparation technique thereof |
08/27/2008 | CN101248809A Method for preparing fresh flower ham (yunnan ham) moon cake |
08/27/2008 | CN100413975C Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product |
08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
08/27/2008 | CN100413883C Peptidic compounds selectively binding to p-selectin |
08/27/2008 | CN100413845C Compounds for modulating cell proliferation |
08/27/2008 | CN100413553C Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leuko-filter |
08/27/2008 | CN100413514C Leaves of cajanus cajan(L.) millsp and extract, formulation and uses thereof |
08/27/2008 | CN100413513C Medication for treating neonatal jaundice, and method of use |
08/27/2008 | CN100413509C Use of lambda-carrageenan oligose in preparing blood vessel proliferation inhibitor |
08/26/2008 | US7417118 Pharmaceutical composition containing artificial oxygen carrier |
08/26/2008 | US7417033 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
08/26/2008 | US7416887 Preparing viable stem cells in culture; prepare nutrient broth containing ligand and preferential receptor, inoculate with cells, monitor propagation and viability of cells |
08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
08/26/2008 | CA2312021C Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
08/26/2008 | CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase |
08/21/2008 | WO2008100453A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
08/21/2008 | WO2008100258A1 Intraperitoneal administration of antithrombin iii, related compositions and methods |
08/21/2008 | WO2008100140A1 Treatment of trauma hemorrhage with short oligopeptides |
08/21/2008 | WO2008098720A1 Therapeutic application of kazal-type serine protease inhibitors |
08/21/2008 | WO2008082613A9 Factor ix moiety-polymer conjugates having a releasable linkage |
08/21/2008 | WO2007146425A3 Compounds and methods for treatment of chemotherapy-induced anemia |
08/21/2008 | WO2007101698A3 Modified molecules which promote hematopoiesis |
08/21/2008 | US20080200674 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents;Alzheimer's disease; anticancer agents |
08/21/2008 | US20080200646 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin) |
08/21/2008 | US20080200532 Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them |
08/21/2008 | US20080200511 Novel Compounds and Methods of Using the Same |
08/21/2008 | US20080200484 Pharmaceutical Compositions Comprising A Multifunctional Phosphodiesterase Inhibitor and An Adenosine Uptake Inhibitor |
08/21/2008 | US20080200448 New Pyridine Analogues VIII 518 |
08/21/2008 | US20080200437 Polyphosphorylated inositol derivatives; allosteric effectors, cell signaling molecule analogs; hypoxia related diseases |
08/21/2008 | US20080200431 Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa |
08/21/2008 | US20080200421 Heparin linked to bioabsorbable polylactone; restenosis prevention; stent implants; synthesis |
08/21/2008 | US20080200420 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
08/21/2008 | US20080200407 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
08/21/2008 | US20080200387 Anti-angiogenic protein, composition and use thereof |
08/21/2008 | US20080200371 Thiazole and thiadiazole inhibitors of tyrosine phosphatases |
08/21/2008 | US20080199865 Using allelic variation in interleukin-1RN variable number of tandem repeats as diagnostic/prognostic indicator of decrease cell division and aging characteristics |
08/21/2008 | US20080199398 Polypeptide conjugate comprising helices of ApoA-1 apolipoproteins and peptide linking groups; antiinflammatory domain and/or domain that effects lecithin-cholesterol acyltransferase (LCAT); dyslipidemic disorders, stroke and myocardial infarction; cardiovascular disorders; detecting plaque |
08/21/2008 | DE102007008484A1 Pharmazeutische Zubereitung zur Bekämpfung von Metastasen Pharmaceutical composition for controlling metastases |
08/21/2008 | CA2678127A1 Tgf-beta stimulant and further agent to reduce side effects |
08/21/2008 | CA2678064A1 Intraperitoneal administration of antithrombin iii, related compositions and methods |
08/21/2008 | CA2678001A1 Therapeutic application of kazal-type serine protease inhibitors |
08/21/2008 | CA2677948A1 Treatment of trauma-hemorrhage with short oligopeptides |
08/21/2008 | CA2677747A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
08/20/2008 | EP1959013A1 Human circulating virus inhibitory peptide (VRIP) and its use |
08/20/2008 | EP1958965A2 Agonist antibodies to a musk receptor, and their therapeutic uses |
08/20/2008 | EP1958648A1 Therapeutic method for blood coagulation disorder |
08/20/2008 | EP1957517A2 Use of peptides that bind to tpo receptor |
08/20/2008 | EP1957062A2 Unsaturated fatty acids as thrombin inhibitors |
08/20/2008 | EP1616873B1 Lipid-regulating agent and use thereof |
08/20/2008 | EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
08/20/2008 | EP1176969B1 Substitution infusion fluid and citrate anticoagulation |
08/20/2008 | EP1087992B1 Antithrombotic compounds |
08/20/2008 | EP1044017B1 Supplement for dialysis patients |
08/20/2008 | CN101247813A Iron (III) complex compounds for treating iron deficiency in patients with chronic inflammatory intestinal diseases |
08/20/2008 | CN101247794A Formulation for a viptadil |
08/20/2008 | CN101245344A Eriocheir sinensis lipotropism polyoses factor gene and encoding protein and application |
08/20/2008 | CN101245109A Polyglycol single-modificatory recombined human granular leukocyte colony stimulating factor mutant and preparation method thereof |
08/20/2008 | CN101245035A Hydroxamic acid derivant, preparation method and antineoplastic application |
08/20/2008 | CN101244222A Medicine for fish without harm |
08/20/2008 | CN101244214A Method of preparing Chinese medicine for treating idiopathic thromboeytopenic purpura idiopathic thromboeytopenic purpura |
08/20/2008 | CN101244209A Medicament for preventing or treating cardiovascular and cerebrovascular diseases |
08/20/2008 | CN101244206A Pharmaceutical combination for treating cerebral thrombus and preparation thereof |
08/20/2008 | CN101244164A Medicament for preventing and treating hydropsy of pigling |
08/20/2008 | CN101244163A Tableland yak blood capsule and preparation thereof |
08/20/2008 | CN101244121A Leonurus heterophyllus total alkaloid extract and preparation thereof |